• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Webinars and One-pagers HepVu Webinar: Harm Reduction Services in the Time of COVID-19

HepVu Webinar: Harm Reduction Services in the Time of COVID-19

June 11, 2020

On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.

To view the recording of the HepVu webinar on “HepVu Webinar: Harm Reduction Services in the Time of COVID-19” please see the video below.

Moderator:
  • Heather Bradley, PhD, Assistant Professor of Epidemiology, Georgia State University, Project Director of HepVu
Speakers:
  • Don Des Jarlais, PhD, Associate Director, Infectious Disease Epidemiology and Theory Core, Center for Drug Use and HIV, and Professor, NYU School of Global Public Health
  • Tyler Bartholomew, Director of Research and Evaluation, The IDEA Exchange
  • Daniel Raymond, Deputy Director of Planning and Policy, Harm Reduction Coalition

To download the presentation, please click here.

Share Facebook Twitter LinkedIn Email

Keep Reading

April 14, 2025

What's New in Viral Hepatitis - April 2025

Read More

February 20, 2025

What's New in Viral Hepatitis - February 2025

Read More

December 11, 2024

What's New in Viral Hepatitis - December 2024

Read More

November 21, 2024

World Hepatitis Testing Week 2024 Toolkit

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.